Respiratory syncytial virus: A review of current basic and clinical knowledge.

BACKGROUND

Respiratory syncytial virus (RSV) is a highly contagious pathogen known for causing respiratory tract infections, particularly among pediatric and elderly patients. Its ability to induce outbreaks in both community and hospital settings underscores its substantial health burden. This review aims to provide a comprehensive understanding of RSV, including its biological and clinical aspects.

METHODS

A comprehensive review of the literature was conducted by searching PubMed, Scopus, and Web of Science databases for relevant articles. Key topics included RSV virology, epidemiology, clinical findings, diagnostic methods, management approaches, and preventive strategies.

RESULTS

This review encompasses the taxonomy and structure of RSV, including its genome and proteins. Various strains and their dominance patterns, alongside pathogenesis mechanisms, are explored. Diagnostic techniques such as nucleic acid amplification tests are discussed for their efficacy and accessibility. Supportive care remains the primary treatment, with antiviral therapies playing a limited role. Monoclonal antibody immunization and vaccination efforts offer promising avenues for RSV prevention. The impact of the COVID-19 pandemic on RSV epidemiology is also considered, along with the oncolytic potential of RSV in cancer treatment.

CONCLUSION

Advancements in understanding RSV virology, epidemiology, and clinical management have paved the way for improved diagnostic and preventive strategies. However, challenges remain in ensuring widespread access to diagnostics and effective treatments, particularly in resource-limited settings. Continued research and global collaboration are essential for addressing the ongoing impact of RSV and reducing its burden on public health.